Zhitong Finance App News, Shengnuo Biotech (688117.SH) issued an announcement. Chengdu Shengnuo Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received a “Drug Registration Certificate” for linaclotide capsules issued by the State Drug Administration.

Zhitongcaijing · 1d ago
Zhitong Finance App News, Shengnuo Biotech (688117.SH) issued an announcement. Chengdu Shengnuo Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received a “Drug Registration Certificate” for linaclotide capsules issued by the State Drug Administration.